Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
P. 1
who 2011

who 2011

Ratings: (0)|Views: 2|Likes:
Published by sightbd

More info:

Published by: sightbd on Jun 20, 2012
Copyright:Attribution Non-commercial


Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less





Guidelines orthe programmaticmanagement odrug-resistanttuberculosis
2011 update
Design by Inís Communication – www.iniscommunication.com
Tis guideline was developed in compliance with the process or evidence gathering, assessment and  ormulation o recommendations, as outlined in the WHO Handbook or Guideline Development (version March 2010; available at www.who.int/hiv/topics/mtct/grc_handbook_mar2010_1.pd).
First edition, 2006Emergency update, 20082011 updateWHO Library Cataloguing-in-Publication DataGuidelines or the programmatic management o drug-resistant tuberculosis – 2011 update.1.uberculosis, Multidrug-resistant – drug therapy. 2.uberculosis, Multidrug-resistant – preventionand control. 3.Antitubercular agents – administration and dosage. 4.HIV inections – drug therapy.5.Antiretroviral therapy, Highly active. 6.Guidelines.I.World Health Organization.ISBN 978 92 4 150158 3 (NLM classifcation: WF 310)© World Health Organization 2011All rights reserved. Publications o the World Health Organization are available on the WHOweb site (www.who.int) or can be purchased rom WHO Press, World Health Organization, 20Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; ax: +41 22 791 4857; e-mail:bookorders@who.int).Requests or permission to reproduce or translate WHO publications – whether or sale or ornoncommercial distribution – should be addressed to WHO Press through the WHO web site(http://www.who.int/about/licensing/copyright_orm/en/index.html).Te designations employed and the presentation o the material in this publication do not imply theexpression o any opinion whatsoever on the part o the World Health Organization concerning thelegal status o any country, territory, city or area or o its authorities, or concerning the delimitationo its rontiers or boundaries. Dotted lines on maps represent approximate border lines or whichthere may not yet be ull agreement.Te mention o specifc companies or o certain manuacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preerence to others o a similarnature that are not mentioned. Errors and omissions excepted, the names o proprietary productsare distinguished by initial capital letters.All reasonable precautions have been taken by the World Health Organization to veriy theinormation contained in this publication. However, the published material is being distributedwithout warranty o any kind, either expressed or implied. Te responsibility or the interpretationand use o the material lies with the reader. In no event shall the World Health Organization beliable or damages arising rom its use.Printed by the WHO Document Production Services, Geneva, Switzerland.WHO/HM/B/2011.6
Guidelines orthe programmaticmanagement odrug-resistanttuberculosis
2011 update

You're Reading a Free Preview

/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->